The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Lyophilized IVIG Market Research Report 2024
Synopsis
Intravenous immunoglobulin (IVIG) contains the pooled immunoglobulin G (IgG) immunoglobulins from the plasma of approximately a thousand or more blood donors.
The global Lyophilized IVIG market was valued at US$ 145 million in 2023 and is anticipated to reach US$ 246.4 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.
This report aims to provide a comprehensive presentation of the global market for Lyophilized IVIG, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lyophilized IVIG.
Report Scope
The Lyophilized IVIG market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lyophilized IVIG market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lyophilized IVIG manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Segment by Type
2.5g
1.25g
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lyophilized IVIG manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lyophilized IVIG in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Intravenous immunoglobulin (IVIG) contains the pooled immunoglobulin G (IgG) immunoglobulins from the plasma of approximately a thousand or more blood donors.
The global Lyophilized IVIG market was valued at US$ 145 million in 2023 and is anticipated to reach US$ 246.4 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.
This report aims to provide a comprehensive presentation of the global market for Lyophilized IVIG, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lyophilized IVIG.
Report Scope
The Lyophilized IVIG market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lyophilized IVIG market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lyophilized IVIG manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Segment by Type
2.5g
1.25g
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lyophilized IVIG manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lyophilized IVIG in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Lyophilized IVIG Market Overview
1.1 Product Overview and Scope of Lyophilized IVIG
1.2 Lyophilized IVIG Segment by Type
1.2.1 Global Lyophilized IVIG Market Value Comparison by Type (2024-2030)
1.2.2 2.5g
1.2.3 1.25g
1.3 Lyophilized IVIG Segment by Application
1.3.1 Global Lyophilized IVIG Market Value by Application: (2024-2030)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Lyophilized IVIG Market Size Estimates and Forecasts
1.4.1 Global Lyophilized IVIG Revenue 2019-2030
1.4.2 Global Lyophilized IVIG Sales 2019-2030
1.4.3 Global Lyophilized IVIG Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Lyophilized IVIG Market Competition by Manufacturers
2.1 Global Lyophilized IVIG Sales Market Share by Manufacturers (2019-2024)
2.2 Global Lyophilized IVIG Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Lyophilized IVIG Average Price by Manufacturers (2019-2024)
2.4 Global Lyophilized IVIG Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Lyophilized IVIG, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lyophilized IVIG, Product Type & Application
2.7 Lyophilized IVIG Market Competitive Situation and Trends
2.7.1 Lyophilized IVIG Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Lyophilized IVIG Players Market Share by Revenue
2.7.3 Global Lyophilized IVIG Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lyophilized IVIG Retrospective Market Scenario by Region
3.1 Global Lyophilized IVIG Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Lyophilized IVIG Global Lyophilized IVIG Sales by Region: 2019-2030
3.2.1 Global Lyophilized IVIG Sales by Region: 2019-2024
3.2.2 Global Lyophilized IVIG Sales by Region: 2025-2030
3.3 Global Lyophilized IVIG Global Lyophilized IVIG Revenue by Region: 2019-2030
3.3.1 Global Lyophilized IVIG Revenue by Region: 2019-2024
3.3.2 Global Lyophilized IVIG Revenue by Region: 2025-2030
3.4 North America Lyophilized IVIG Market Facts & Figures by Country
3.4.1 North America Lyophilized IVIG Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Lyophilized IVIG Sales by Country (2019-2030)
3.4.3 North America Lyophilized IVIG Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Lyophilized IVIG Market Facts & Figures by Country
3.5.1 Europe Lyophilized IVIG Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Lyophilized IVIG Sales by Country (2019-2030)
3.5.3 Europe Lyophilized IVIG Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lyophilized IVIG Market Facts & Figures by Country
3.6.1 Asia Pacific Lyophilized IVIG Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Lyophilized IVIG Sales by Country (2019-2030)
3.6.3 Asia Pacific Lyophilized IVIG Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Lyophilized IVIG Market Facts & Figures by Country
3.7.1 Latin America Lyophilized IVIG Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Lyophilized IVIG Sales by Country (2019-2030)
3.7.3 Latin America Lyophilized IVIG Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lyophilized IVIG Market Facts & Figures by Country
3.8.1 Middle East and Africa Lyophilized IVIG Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Lyophilized IVIG Sales by Country (2019-2030)
3.8.3 Middle East and Africa Lyophilized IVIG Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lyophilized IVIG Sales by Type (2019-2030)
4.1.1 Global Lyophilized IVIG Sales by Type (2019-2024)
4.1.2 Global Lyophilized IVIG Sales by Type (2025-2030)
4.1.3 Global Lyophilized IVIG Sales Market Share by Type (2019-2030)
4.2 Global Lyophilized IVIG Revenue by Type (2019-2030)
4.2.1 Global Lyophilized IVIG Revenue by Type (2019-2024)
4.2.2 Global Lyophilized IVIG Revenue by Type (2025-2030)
4.2.3 Global Lyophilized IVIG Revenue Market Share by Type (2019-2030)
4.3 Global Lyophilized IVIG Price by Type (2019-2030)
5 Segment by Application
5.1 Global Lyophilized IVIG Sales by Application (2019-2030)
5.1.1 Global Lyophilized IVIG Sales by Application (2019-2024)
5.1.2 Global Lyophilized IVIG Sales by Application (2025-2030)
5.1.3 Global Lyophilized IVIG Sales Market Share by Application (2019-2030)
5.2 Global Lyophilized IVIG Revenue by Application (2019-2030)
5.2.1 Global Lyophilized IVIG Revenue by Application (2019-2024)
5.2.2 Global Lyophilized IVIG Revenue by Application (2025-2030)
5.2.3 Global Lyophilized IVIG Revenue Market Share by Application (2019-2030)
5.3 Global Lyophilized IVIG Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Lyophilized IVIG Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Grifols Lyophilized IVIG Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 CSL
6.3.1 CSL Corporation Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL Lyophilized IVIG Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Lyophilized IVIG Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Biotest
6.5.1 Biotest Corporation Information
6.5.2 Biotest Description and Business Overview
6.5.3 Biotest Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biotest Lyophilized IVIG Product Portfolio
6.5.5 Biotest Recent Developments/Updates
6.6 Kedrion
6.6.1 Kedrion Corporation Information
6.6.2 Kedrion Description and Business Overview
6.6.3 Kedrion Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kedrion Lyophilized IVIG Product Portfolio
6.6.5 Kedrion Recent Developments/Updates
6.7 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hualan Bio Lyophilized IVIG Product Portfolio
6.7.5 Hualan Bio Recent Developments/Updates
6.8 CNBG
6.8.1 CNBG Corporation Information
6.8.2 CNBG Description and Business Overview
6.8.3 CNBG Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CNBG Lyophilized IVIG Product Portfolio
6.8.5 CNBG Recent Developments/Updates
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Corporation Information
6.9.2 Shanghai RAAS Description and Business Overview
6.9.3 Shanghai RAAS Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Shanghai RAAS Lyophilized IVIG Product Portfolio
6.9.5 Shanghai RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Corporation Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CBPO Lyophilized IVIG Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 LFB Group
6.11.1 LFB Group Corporation Information
6.11.2 LFB Group Lyophilized IVIG Description and Business Overview
6.11.3 LFB Group Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
6.11.4 LFB Group Lyophilized IVIG Product Portfolio
6.11.5 LFB Group Recent Developments/Updates
6.12 BPL
6.12.1 BPL Corporation Information
6.12.2 BPL Lyophilized IVIG Description and Business Overview
6.12.3 BPL Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
6.12.4 BPL Lyophilized IVIG Product Portfolio
6.12.5 BPL Recent Developments/Updates
6.13 Sichuan Yuanda Shuyang
6.13.1 Sichuan Yuanda Shuyang Corporation Information
6.13.2 Sichuan Yuanda Shuyang Lyophilized IVIG Description and Business Overview
6.13.3 Sichuan Yuanda Shuyang Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Sichuan Yuanda Shuyang Lyophilized IVIG Product Portfolio
6.13.5 Sichuan Yuanda Shuyang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lyophilized IVIG Industry Chain Analysis
7.2 Lyophilized IVIG Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lyophilized IVIG Production Mode & Process
7.4 Lyophilized IVIG Sales and Marketing
7.4.1 Lyophilized IVIG Sales Channels
7.4.2 Lyophilized IVIG Distributors
7.5 Lyophilized IVIG Customers
8 Lyophilized IVIG Market Dynamics
8.1 Lyophilized IVIG Industry Trends
8.2 Lyophilized IVIG Market Drivers
8.3 Lyophilized IVIG Market Challenges
8.4 Lyophilized IVIG Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
